BRSJX
Price
$14.68
Change
+$0.11 (+0.75%)
Updated
Jul 8 closing price
Net Assets
317.83M
VSCIX
Price
$115.84
Change
+$0.53 (+0.46%)
Updated
Jul 8 closing price
Net Assets
153.28B
Interact to see
Advertisement

BRSJX vs VSCIX

Header iconBRSJX vs VSCIX Comparison
Open Charts BRSJX vs VSCIXBanner chart's image
MFS Blended Research Small Cap Eq I
Price$14.68
Change+$0.11 (+0.75%)
VolumeN/A
Net Assets317.83M
Vanguard Small Cap Index I
Price$115.84
Change+$0.53 (+0.46%)
VolumeN/A
Net Assets153.28B
BRSJX vs VSCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRSJX vs. VSCIX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSJX is a Hold and VSCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 153B vs. BRSJX (318M). VSCIX (1.41) and BRSJX (1.35) have matching dividends . BRSJX was incepted earlier than VSCIX: BRSJX (10 years) vs VSCIX (28 years). BRSJX (0.88) is less costly to investors than VSCIX (0.04). BRSJX is a more actively managed with annual turnover of: 61.00 vs. VSCIX (13.00). BRSJX has a lower initial minimum investment than VSCIX: BRSJX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 11.19 vs. BRSJX (-0.35). VSCIX return over 5 years is better than : 69.78 vs. BRSJX (35.19).
BRSJXVSCIXBRSJX / VSCIX
Total Expense Ratio0.740.041,850%
Annual Report Gross Expense Ratio0.880.042,200%
Fund Existence10 years28 years-
Gain YTD-1.2780.309-414%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets318M153B0%
Annual Yield % from dividends1.351.4196%
Returns for 1 year-0.3511.19-3%
Returns for 3 years10.8534.0932%
Returns for 5 years35.1969.7850%
Returns for 10 yearsN/A106.48-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNGX5.700.27
+4.97%
Tango Therapeutics
AVTR13.750.24
+1.78%
Avantor
CRNX29.370.31
+1.07%
Crinetics Pharmaceuticals
BVFL15.940.11
+0.69%
BV Financial
POAI0.80-0.05
-5.88%
Predictive Oncology